1DIMOPOULOS M A,GERTZ M A,KASTRITIS E,et al.Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia[J].J Clin Oncol,2009,27:120-126.
2ARSLAN O,ARAT M,TEK I,et al.Therapeutic plasma exchange in a single center:Ibni Sina experience[J].Transfus Apher Sci,2004,30:181-184.
3DHODAPKAR M V,JACOBSON J L,GERTZ M A,et al.Prognostic factors and response to fludarabine therapy in Waldenstrm's macroglobulinemia:an update of a US intergroup trial (SWOG S9003)[J].Semin Oncol,2003,30:220-225.
4FORAN J M,ROHATINER A Z,COIFFIER B,et al.Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma,Waldenstrm's macroglobulinemia,and mantle-cell lymphoma[J].J Clin Oncol,1999,17:546-553.
5WEBER DONNA M,DIMOPOULOS MELETIOS A,DELASALLE K,et al.2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia[J].Semin Oncol,2003,30:243-247.
6DIMOPOULOS M A,WEBER D M,KANTARJIAN H,et al.2-Chlorodeoxyadenosine therapy of patients with Waldenstrm macroglobulinemia previously treated with fludarabine[J].Ann Oncol,1994,5:288-289.
7KYLE R A,GREIPP P R,GERTZ M A,et al.Waldenstrom's macroglobulinaemia:a prospective study comparing daily with intermittent oral chlorambucil[J].Br J Haematol,2000,108:737-742.
8RODRIGUEZ J N,FERNANDEZ-JURADO A,MARTINO M L,et al.Waldenstrom's macroglobulinemia complicated with acute myeloid leukemia.Report of a case and review of the literature[J].Haematologica,1998,83:91-92.
9DIMOPOULOS M A,ZERVAS C,ZOMAS A,et al.Extended rituximab therapy for previously untreated patients with Waldenstrom's macroglobulinemia[J].Clin Lymphoma,2002,3:163-166.
10GERTZ M A,RUE M,BLOOD E,KAMINER L S,et al.Multicenter phase 2 trial of rituximab for Waldenstrom macroglobulinemia (WM):an Eastern Cooperative Oncology Group Study (E3A98)[J].Leuk Lymphoma,2004,45:2047-2055.
